Cresilon’s Post

View organization page for Cresilon, graphic

11,149 followers

Our preclinical study with Walter Reed Army Institute of Research (WRAIR) shows promising results for treating penetrating traumatic brain injury (TBI). This study evaluated the safety and efficacy of our hemostatic gel technology in treating TBI. Why does this matter? Penetrating TBI (such as from a gunshot or shrapnel) is the most severe form of traumatic head injury and can lead to death, permanent disability, neurodegenerative diseases, and long-term health issues. Since the DOD began tracking and reporting the number of service members diagnosed with TBI, a total of 492,167 service members sustained one or more TBIs, 5,766 of which were classified as penetrating TBI. "TBIs significantly impact the health, preparedness, and resilience of military personnel," said Dr. Anke Scultetus, WRAIR. "The results of this study with Cresilon are encouraging as we work to deliver solutions for medical personnel and our injured service members." Learn more at https://lnkd.in/e6zG4jN8 #TraumaticBrainInjury #HealthcareInnovation #EmergencyMedicine #TRAUMAGEL

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics